Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with Schedule III to the said Regulations, Gujarat Terce Laboratories has informed that the Board of Directors of the Company, at its Meeting held today on Monday, 24th January, 2022 which commenced at 11:00 am and concluded at 12.:05 pm, have approved / noted the following: Approval of Unaudited Standalone Financial Results for the Quarter ended on December 31, 2021: Upon recommendation of the Audit Committee, the Board of Directors have approved the Unaudited Standalone Financial Results as per Indian Accounting Standards (INDAS) for the Quarter and nine months ended on December 31, 2021 (enclosed) and the same is also available on the website of the company at www.gujaratterce.in /Investor and The Limited Review Report of the Statutory Auditors (M.A. Shah & Co.) is with unmodified opinion with respect to the Unaudited Standalone Financial Results of the Company for the Quarter and nine months ended December 31, 2021 (enclosed), the Board of Directors took note of the same.
The above information is a part of company’s filings submitted to BSE.
